Friday, July 15, 2011

The Medicines Patent Pool Announces First Licensing Agreement with a Pharmaceutical Company

London, 12 July 2011: Today the Medicines Patent Pool announces its first licenses with a pharmaceutical company, Gilead Sciences, to increase access to HIV and Hepatitis B treatment in developing countries.

Photo from Medicines Patent Pool web site

* * *

The Medicines Patent Pool and UNITAID joint press release is available here [pdf], and also posted below.

Questions and answers on the Patent Pool licenses are available here [pdf].

Per the Medicines Patent Pool transparency policy [pdf], the full texts of the licenses are posted below.

The main licensing agreement between the Medicines Patent Pool and Gilead is available here [pdf].